Implantica announces that RefluxStop™ results were presented at the DDW Conference in Chicago
Retrieved on:
Tuesday, May 16, 2023
VADUZ, Liechtenstein, May 16, 2023 /PRNewswire/ -- Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that Dr. med.
Key Points:
- VADUZ, Liechtenstein, May 16, 2023 /PRNewswire/ -- Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces that Dr. med.
- Zehetner, Prof. (USC) from Switzerland, presented Klinik Beau-Site's RefluxStop™ results at Digestive Disease Week (DDW) 6-9 May, in Chicago, U.S., the world's premier meeting for gastrointestinal professionals
Dr. med. - Support from key opinion leaders and clinical data are crucial for Implantica as we work to obtain reimbursement across Europe.
- "Implantica is also proud to announce that we have started our marketing process in the U.S. preparing the ground for the future U.S. approval.